MPWT
SCPH

MassMutual Private Wealth & Trust’s scPharmaceuticals SCPH Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-389
Closed -$1.69K – 2245
2024
Q2 		$1.69K Buy
+389
New +$1.71K ﹤0.01% 1691

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

MassMutual Private Wealth & Trust's SCPH Position: Q3 2024 in Review

MassMutual Private Wealth & Trust sold out of scPharmaceuticals (SCPH) in Q3 2024, closing a stake of 389 shares — an estimated $1.69K sold.

MassMutual Private Wealth & Trust first reported a position in SCPH in Q2 2024 and held it in 1 quarter. The position peaked at $1.69K in Q2 2024. 95 funds tracked by Wall St. Rank hold SCPH as of Q3 2024.

  • MassMutual Private Wealth & Trust reported no remaining scPharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 389 scPharmaceuticals shares in Q3 2024, an estimated $1.69K.
  • MassMutual Private Wealth & Trust first reported a position in scPharmaceuticals in Q2 2024 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's scPharmaceuticals position peaked at $1.69K in Q2 2024.
  • 95 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2024.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2024, filed 2 Oct 2024.